| Recruiting | THE ROLE OF HEXAMIDINE DIISETHIONATE (ZAMIDINE®) 1MG/ML 0.6ML EYE DROPS IN THE PROPHYLAXIS OF SURGERY OFTALMIC NCT06771908 | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | — |
| Enrolling By Invitation | Investigating Epstein-Barr Virus Associated Conjunctivitis NCT06689397 | Moorfields Eye Hospital NHS Foundation Trust | — |
| Completed | Zanzibar Arts for Children's Eyesight Pilot Trial NCT06469697 | Queen's University, Belfast | N/A |
| Completed | The Effects of a Large Language Model on Clinical Questioning Skills NCT06229379 | Sun Yat-sen University | N/A |
| Completed | Efficacy of Zinc Fortified Fermented Wheat Flour NCT06092515 | Aga Khan University | N/A |
| Completed | Efficacy of the Anti-Bet v 1 Monoclonal Antibodies (Given Subcutaneously) to Reduce Allergic Rhinitis and Conj NCT05430919 | Regeneron Pharmaceuticals | Phase 2 |
| Completed | Observational Study of Conjunctivitis in the Setting of DUPIXENT® Treatment for Atopic Dermatitis NCT04287608 | Regeneron Pharmaceuticals | — |
| Completed | Improving the Follow up Rate for Pediatric Patients NCT04837534 | Seva Foundation | N/A |
| Completed | Study to Assess the Efficacy of Anti-Bet v 1 Monoclonal Antibodies in Adults to Reduce Symptoms of Seasonal Al NCT04709575 | Regeneron Pharmaceuticals | Phase 3 |
| Completed | Prevalence of SARS-CoV-2 in Conjunctival Swab Samples Among Patients With Conjunctivitis During the COVID-19 P NCT04374656 | Johns Hopkins University | — |
| Unknown | A Study to Assess the Virus RNA, and miRNA Levels Related to Viral Infection, and Inflammatory Response in Tea NCT04346160 | G. d'Annunzio University | — |
| Unknown | Feasibility Study and Preliminary Application Study on Iris OCTA NCT03631108 | Shanghai Eye Disease Prevention and Treatment Center | — |
| Completed | Safety and Tolerability of the PRO-174 Versus Sophixín Ofteno®, on the Ocular Surface of Healthy Subjects NCT03519516 | Laboratorios Sophia S.A de C.V. | Phase 1 |
| Withdrawn | Efficacy and Safety of Grass-SPIRE Registration Study NCT02795273 | Circassia Limited | Phase 2 / Phase 3 |
| Completed | Perforated Punctal Plugs for Treatment of Papillary Conjunctivitis in Otherwise Healthy Patients NCT02503956 | Rabin Medical Center | N/A |
| Completed | Reducing Adenoviral Patient Infected Days NCT02472223 | Washington University School of Medicine | N/A |
| Completed | Ocular Manifestations in Rheumatic Diseases NCT03753893 | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | — |
| Completed | Evaluation of the Role of IgE Responses to Der p 1 and Der p 2 in Chinese House Dust Mite-Allergic Patients NCT04984941 | Second Affiliated Hospital, School of Medicine, Zhejiang University | — |
| Unknown | Evaluate the Use of Ganciclovir Gel 0.3% for the Treatment of Conjunctivitis Caused by Adenovirus NCT01600365 | Adapt Produtos Oftalmológicos Ltda. | Phase 3 |
| Completed | A Study of SCH 697243 in Participants With Grass Pollen Allergy Symptoms, With or Without Asthma (P08067) NCT01385371 | ALK-Abelló A/S | Phase 3 |
| Completed | Safety Study of Ragweed Allergy Immunotherapy Tablet in Subjects 50 Years of Age and Older (Study P06081) NCT00978029 | ALK-Abelló A/S | Phase 2 |
| Completed | Loteprednol and Tobramycin Versus Tobramycin and Dexamethasone, in the Treatment of Blepharokeratoconjunctivit NCT01028027 | Bausch & Lomb Incorporated | Phase 3 |
| Completed | Efficacy and Long-Term Safety of Ragweed (Ambrosia Artemisiifolia) Sublingual Tablet (SCH 39641) in Adults Wit NCT00770315 | ALK-Abelló A/S | Phase 2 / Phase 3 |
| Completed | Efficacy and Long-Term Safety of Ragweed (Ambrosia Artemisiifolia) Sublingual Tablet in Adults With a History NCT00783198 | ALK-Abelló A/S | Phase 2 / Phase 3 |
| Completed | A Comparison of the RPS Adeno Detector IV to Viral Cell Culture at Detecting Adenoviral Conjunctivitis NCT00921895 | Rapid Pathogen Screening | N/A |
| Completed | Study on Pharmacodynamic Parameter and Tolerability With Subcutaneous Immunotherapy in Grass Pollen Allergic P NCT00857779 | ALK-Abelló A/S | Phase 2 |
| Completed | Safety/Efficacy of Antibiotic Steroid Combination in Treatment of Blepharitis and/or Keratitis and/or Conjunct NCT00732446 | Federal University of São Paulo | Phase 3 |
| Completed | Safety and Efficacy of Zylet vs Lotemax, Tobramycin and Vehicle in Pediatric Blepharoconjunctivitis NCT00705159 | Bausch & Lomb Incorporated | Phase 4 |
| Completed | Efficacy and Safety From a High-dosed Sublingual Grass Pollen Preparation NCT00623701 | Allergopharma GmbH & Co. KG | Phase 3 |
| Completed | Efficacy and Safety of Grass Sublingual Tablet in Children and Adolescents (P05239 AM3)(COMPLETED) NCT00550550 | ALK-Abelló A/S | Phase 3 |
| Completed | Efficacy and Safety of Grass Sublingual Tablet in Adults (P05238 AM3)(COMPLETED) NCT00562159 | ALK-Abelló A/S | Phase 3 |
| Completed | Moxifloxacin vs. Polytrim for Conjunctivitis NCT00581542 | University of Rochester | Phase 4 |
| Completed | Eye Drop Use in Glaucoma Patients Through Patient Surveys and Video Observations NCT00522600 | Robin, Alan L., M.D. | — |
| Completed | Phase III, Long-Term, Open-Label, Extension Study of 0.1% Tacrolimus(FK506) Ophthalmic Suspension in Patients NCT00567918 | Astellas Pharma Inc | Phase 3 |
| Completed | Phase III Study of 0.1% Tacrolimus(FK506) Ophthalmic Suspension in Patients With Vernal Keratoconjunctivitis NCT00567762 | Astellas Pharma Inc | Phase 3 |
| Completed | Evaluation and Treatment of Patients With Corneal and External Diseases NCT00008541 | National Eye Institute (NEI) | — |
| Completed | Screening for NEI Clinical Studies NCT00001734 | National Eye Institute (NEI) | — |